Advanced Medicine Partners

Advanced Medicine Partners delivers process development, manufacturing, analytical development and testing for advanced therapy products, including gene therapies. The company leverages one of the most experienced genetic medicines teams in the industry, and its exclusive manufacturing platform consistently produces yields that are among the highest in the industry and purity profiles that push the boundaries of what’s possible.

Advanced Medicine Partners’ proprietary adeno-associated virus (AAV) manufacturing process minimizes impurities and consistently generates predominantly functional full capsids and best-in-class yields. This manufacturing process prioritizes patient safety while reducing cost of goods. The company brings extensive operational experience and has manufactured upwards of 350 total non-GMP batches and supplied over 20 preclinical studies, including IND-enabling efficacy and GLP toxicology studies.

We know real-time data helps you drive decisions and accelerate your programs – let us be your extended workbench!